Treatment of neuroendocrine tumours - historical notes
| Date | Note |
|---|---|
| 28/03/2024 | Lantreotide product update, ERWG March 24. |
| 11/05/2023 | Somatuline LA 30mg powder and solvent for suspension for injection vials removed as discontinued. |
| 21/02/2023 | Addition of alternative long-acting octreotide formulation, ERWG Jan 23. |
| 16/02/2022 | East Region Formulary content agreed. |